RE: RE: RE: What if?Jimmy,
Good post. Just to be clear though, I used the term "apparent monopoly" because it appears that way to some posters. I agree with you that right now, ENDO has world rights to Urocidin only. The rest is up for grabs with exception that ENDO has first rights to negotiate on the pelvic products. However BNC hold the patent rights to MCC. If someone should buy out BNC, they would now hold those rights, and it could be an ENDO competitor.
TC9